Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#11 / 200 Total
CRDF - Cardiff Oncology Inc - Stock Price Chart
TickerCRDF [NASD]
CompanyCardiff Oncology Inc
CountryUSA
IndustryBiotechnology
Market Cap130.02MEPS (ttm)-0.93
P/E-EPS this Y-4.22%
Forward P/E-EPS next Y-8.84%
PEG-EPS past 5Y35.42%
P/S265.34EPS next 5Y-
P/B1.86EPS Q/Q-7.34%
Dividend-Sales Q/Q21.87%
Insider Own8.07%Inst Own12.13%
Insider Trans0.84%Inst Trans-10.89%
Short Float2.89%EarningsFeb 29/a
Analyst Recom1.00Target Price7.00
Avg Volume190.08K52W Range0.94 - 2.79
Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. It is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics. The firm's clinical programs include KRAS-Mutated Metastatic Colorectal Cancer (mCRC), Resistant Metastatic Castration-Resistant Prostate Cancer (mCRPC) and relapsed or refractory Acute Myeloid Leukemia (AML). The company was founded by Gabriel M. Cerrone, L. David Tomei, Samuil Umansky, and Hovsep Melkonyan in 1999 and is headquartered in San Diego, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PACE GARY WDirectorDec 19Buy1.3730,00041,100697,761Dec 19 06:39 PM
KUKE - Kuke Music Holding Ltd ADR - Stock Price Chart
TickerKUKE [NYSE]
CompanyKuke Music Holding Ltd ADR
CountryChina
IndustryEntertainment
Market Cap47.50MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B6.82EPS Q/Q175.87%
Dividend-Sales Q/Q-41.84%
Insider Own-Inst Own0.02%
Insider Trans-Inst Trans-22.33%
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume33.91K52W Range0.42 - 2.10
Kuke Music Holding Ltd. is an investment holding company, which engages in the distribution of commercial copyrights, provision of music education solutions, sales of musical instruments, and provision of services related to music events and performances. It operates through the following business segments: Subscription, Licensing, and Smart Education, and Music Events and Performances. The Subscription, Licensing, and Smart Education segment distributes commercial copyrights and provision of music education solutions. The Music Events and Performances segment offers services related to music festival events and music performance and sale of Conch Smart Speakers. The company was founded by Yu He in 2007 and is headquartered in Beijing, China.
NUVB - Nuvation Bio Inc - Stock Price Chart
TickerNUVB [NYSE, RUT]
CompanyNuvation Bio Inc
CountryUSA
IndustryBiotechnology
Market Cap490.47MEPS (ttm)-0.35
P/E-EPS this Y-6.95%
Forward P/E-EPS next Y-29.12%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B0.81EPS Q/Q33.96%
Dividend-Sales Q/Q-
Insider Own34.65%Inst Own53.92%
Insider Trans7.49%Inst Trans-8.55%
Short Float1.81%EarningsFeb 29/a
Analyst Recom1.80Target Price3.47
Avg Volume747.67K52W Range0.95 - 2.13
Nuvation Bio, Inc. is a biopharmaceutical company tackling some of the unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its proprietary portfolio includes six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer. The company was founded by David Hung on March 20, 2018 and is headquartered in New York, NY.
DYN - Dyne Therapeutics Inc - Stock Price Chart
TickerDYN [NASD, RUT]
CompanyDyne Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap2.36BEPS (ttm)-3.59
P/E-EPS this Y-17.17%
Forward P/E-EPS next Y17.15%
PEG-EPS past 5Y-135.08%
P/S-EPS next 5Y-
P/B11.75EPS Q/Q-23.32%
Dividend-Sales Q/Q-
Insider Own52.37%Inst Own52.74%
Insider Trans-5.71%Inst Trans-3.55%
Short Float18.76%EarningsOct 30/b
Analyst Recom1.00Target Price34.67
Avg Volume1.91M52W Range6.40 - 27.61
Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brumm Joshua TCEO & PresidentMar 01Option Exercise5.5494,480523,419657,951Mar 01 09:38 PM
McNeill JonathanChief Business OfficerMar 01Option Exercise0.7324,26017,710167,878Mar 01 09:37 PM
Scalzo Richard WilliamSVP, Head of Finance & Admin.Mar 01Option Exercise1.039,3119,590133,539Mar 01 09:37 PM
Brumm Joshua TCEO & PresidentMar 01Sale29.0494,4802,743,718563,471Mar 01 09:38 PM
McNeill JonathanChief Business OfficerMar 01Sale28.6324,260694,495143,618Mar 01 09:37 PM
SANA - Sana Biotechnology Inc - Stock Price Chart
TickerSANA [NASD, RUT]
CompanySana Biotechnology Inc
CountryUSA
IndustryBiotechnology
Market Cap2.48BEPS (ttm)-1.46
P/E-EPS this Y18.26%
Forward P/E-EPS next Y-14.13%
PEG-EPS past 5Y-83.13%
P/S-EPS next 5Y-
P/B7.76EPS Q/Q-5.73%
Dividend-Sales Q/Q-
Insider Own50.59%Inst Own40.52%
Insider Trans5.07%Inst Trans1.65%
Short Float20.27%EarningsFeb 29/a
Analyst Recom1.40Target Price12.50
Avg Volume3.37M52W Range2.74 - 10.95
Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses on identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 2018 and is headquartered in Seattle, WA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NELSEN ROBERTDirectorFeb 08Buy5.501,818,1819,999,99612,446,022Feb 12 05:46 PM
CRANDELL KEITH10% OwnerFeb 08Buy5.501,818,1819,999,99612,446,022Feb 12 05:43 PM
ARCH Venture Fund X, L.P.10% OwnerFeb 08Buy5.501,818,1819,999,99612,446,022Feb 12 05:43 PM
Hordo ChristianEVP, Chief Business OfficerDec 15Sale4.0075,000300,098867,455Dec 18 04:51 PM
Flagship Ventures Fund V Gener10% OwnerJun 07Sale6.24200,0001,247,9401,380,277Jun 08 07:00 PM
CLS - Celestica, Inc. - Stock Price Chart
TickerCLS [NYSE]
CompanyCelestica, Inc.
CountryCanada
IndustryElectronic Components
Market Cap5.39BEPS (ttm)2.04
P/E22.21EPS this Y20.37%
Forward P/E13.92EPS next Y11.28%
PEG0.83EPS past 5Y23.48%
P/S0.68EPS next 5Y26.80%
P/B3.42EPS Q/Q103.41%
Dividend-Sales Q/Q4.79%
Insider Own1.39%Inst Own71.11%
Insider Trans0.00%Inst Trans-10.30%
Short Float2.23%EarningsJan 29/a
Analyst Recom1.56Target Price40.20
Avg Volume2.00M52W Range10.50 - 42.87
Celestica, Inc. engages in the provision of supply chain solutions globally to equipment manufacturers and service providers. It operates through the following segments: Advanced Technology Solutions (ATS), and Connectivity and Cloud Solutions (CCS). The Advanced Technology Solutions (ATS) segment includes aerospace and defense, industrial, smart energy, health tech, and capital equipment businesses. The Connectivity and Cloud Solutions (CCS) segment consists of enterprise communications, telecommunications, servers, and storage businesses. The company was founded in 1994 and is headquartered in Toronto, Canada.
RPAY - Repay Holdings Corporation - Stock Price Chart
TickerRPAY [NASD, RUT]
CompanyRepay Holdings Corporation
CountryUSA
IndustrySoftware - Infrastructure
Market Cap936.19MEPS (ttm)-1.22
P/E-EPS this Y4.95%
Forward P/E9.57EPS next Y11.86%
PEG-EPS past 5Y-
P/S3.16EPS next 5Y10.59%
P/B1.10EPS Q/Q-965.65%
Dividend-Sales Q/Q4.56%
Insider Own16.85%Inst Own80.67%
Insider Trans-0.32%Inst Trans-4.62%
Short Float2.07%EarningsFeb 29/a
Analyst Recom1.70Target Price11.85
Avg Volume707.76K52W Range5.61 - 9.55
Repay Holdings Corp. engages in the provision of integrated payment processing solutions to vertical markets that have specific and bespoke transactions. It offers payments, instant funding, active safe, AP automation, clearing and settlement, messaging management, STX mortgage transfer automation, virtual debit cards, and value-added services. The company was founded by John Morris and Shaler A. Alias in 2006 and is headquartered in Atlanta, GA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Sullivan Thomas EugeneChief Accounting OfficerNov 22Sale7.4035,000259,000100,302Nov 24 05:00 PM
Hartheimer Robert HermanDirectorSep 15Sale8.006,87454,99263,331Sep 18 05:00 PM
Hartheimer Robert HermanDirectorSep 14Sale7.965,00039,80070,205Sep 18 05:00 PM
Hartheimer Robert HermanDirectorSep 01Sale9.405,00047,00075,205Sep 06 05:00 PM
Dempsey Tyler BGeneral CounselAug 17Sale9.0450,000452,000209,194Aug 18 05:00 PM
RLMD - Relmada Therapeutics Inc - Stock Price Chart
TickerRLMD [NASD]
CompanyRelmada Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap204.68MEPS (ttm)-3.71
P/E-EPS this Y38.19%
Forward P/E-EPS next Y19.29%
PEG-EPS past 5Y-20.57%
P/S-EPS next 5Y-
P/B2.03EPS Q/Q44.25%
Dividend-Sales Q/Q-
Insider Own15.90%Inst Own52.53%
Insider Trans3.72%Inst Trans4.27%
Short Float6.85%EarningsNov 08/a
Analyst Recom2.20Target Price10.38
Avg Volume319.21K52W Range2.00 - 6.38
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on addressing diseases of the central nervous system. It develops esmethadone, an N-methyl-D-aspartate receptor antagonist for the treatment of CNS diseases, and oral agent for depression and other potential indications. The company was founded by Paolo Manfredi on May 31, 2012 and is headquartered in Coral Gables, FL.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
TRAVERSA SERGIOChief Executive OfficerJan 31Buy4.0027,460109,752244,024Jan 31 06:29 PM
Ence ChuckCA and COJan 31Buy4.0513,67055,42938,970Jan 31 06:28 PM
Shenouda MagedChief Financial OfficerJan 31Buy4.066,87527,94334,903Jan 31 06:28 PM
TRAVERSA SERGIOChief Executive OfficerJan 30Buy3.9040,999159,949216,564Jan 31 06:29 PM
Shenouda MagedChief Financial OfficerJan 30Buy3.8915,00058,32328,028Jan 31 06:28 PM
IRON - Disc Medicine Inc - Stock Price Chart
TickerIRON [NASD, RUT]
CompanyDisc Medicine Inc
CountryUSA
IndustryBiotechnology
Market Cap1.82BEPS (ttm)-3.74
P/E-EPS this Y92.78%
Forward P/E-EPS next Y-29.02%
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B5.06EPS Q/Q23.32%
Dividend-Sales Q/Q-
Insider Own48.43%Inst Own53.05%
Insider Trans-15.47%Inst Trans4.20%
Short Float9.74%EarningsNov 09/b
Analyst Recom1.22Target Price76.56
Avg Volume274.80K52W Range18.25 - 70.27
Feb-26-24 08:30AM Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer (GlobeNewswire)
Feb-20-24 08:30AM Disc Medicine Receives FDA Fast Track Designation for DISC-0974 for the Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease (GlobeNewswire)
Feb-09-24 09:00AM Disc Medicine Receives FDA Orphan Drug Designation for DISC-3405 for the Treatment of Polycythemia Vera (GlobeNewswire)
Feb-07-24 08:00AM Disc Medicine Strengthens Leadership Team with Appointment of Seasoned Industry Executive Jean Franchi as Chief Financial Officer, and Promotion of Jonathan Yu to Chief Operating Officer (GlobeNewswire)
Jan-03-24 05:00PM Disc Medicine to Present at the 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-22-23 06:35PM Peabody Energy, Janus International, and More Stocks See Action From Activist Investors (Barrons.com)
Dec-20-23 04:30PM Disc Medicine Announces Retirement of Brian MacDonald, MB, ChB, PhD as Chief Innovation Officer and Appointment as Chair of Scientific Advisory Board (GlobeNewswire)
Dec-15-23 03:01PM Insider Sell Alert: Director William White Sells 33,511 Shares of Disc Medicine Inc (IRON) (GuruFocus.com)
Dec-11-23 08:30PM Disc Presents Positive Updated Results from Phase 2 BEACON Study of Bitopertin and Other Programs at the 65th American Society of Hematology (ASH) Annual Meeting (GlobeNewswire)
12:00PM Disc Presents Initial Positive Data from Ongoing Phase 1b/2 Trial of DISC-0974 in Patients with Myelofibrosis (MF) and Anemia at the 65th American Society of Hematology (ASH) Annual Meeting (GlobeNewswire)
Disc Medicine, Inc. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel treatments for hematologic disorders. Its programs include Bitopertin, DISC-0974, and DISC-3405. The company was founded in October 2017 and is headquartered in Watertown, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Atlas Venture Fund X, L.P.10% OwnerJan 23Sale67.65102,5006,934,125198,326Jan 25 04:31 PM
Bitterman KevinDirectorJan 23Sale67.65102,5006,934,125198,326Jan 25 04:33 PM
Atlas Venture Fund X, L.P.10% OwnerJan 23Sale67.6547,5003,213,3751,402,186Jan 25 04:31 PM
Atlas Venture Fund X, L.P.10% OwnerJan 10Sale64.0030,0001,920,0001,449,686Jan 12 05:12 PM
Atlas Venture Fund X, L.P.10% OwnerJan 10Sale64.0020,0001,280,000786,160Jan 12 05:12 PM
TDW - Tidewater Inc. - Stock Price Chart
TickerTDW [NYSE, RUT]
CompanyTidewater Inc.
CountryUSA
IndustryOil & Gas Equipment & Services
Market Cap4.19BEPS (ttm)1.83
P/E43.70EPS this Y212.59%
Forward P/E9.20EPS next Y57.31%
PEG8.74EPS past 5Y-
P/S4.14EPS next 5Y5.00%
P/B4.03EPS Q/Q240.41%
Dividend1.07%Sales Q/Q62.07%
Insider Own7.68%Inst Own95.77%
Insider Trans-0.45%Inst Trans19.53%
Short Float9.00%EarningsMar 01/b
Analyst Recom1.00Target Price87.00
Avg Volume722.79K52W Range37.76 - 77.53
Tidewater, Inc. engages in the provision of offshore marine support and transportation services to the offshore energy industry. The firm offers the towing of, and anchor handling for, mobile offshore drilling units, transporting supplies and personnel necessary to sustain drilling, work over and production activities, offshore construction and seismic and subsea support, geotechnical survey for wind farm construction, and a variety of specialized services such as pipe and cable laying. It operates through the following geographical segments: Americas, Asia Pacific, Middle East, Europe and Mediterranean, and West Africa. The company was founded in 1955 and is headquartered in Houston, TX.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ROBOTTI ROBERTDirectorSep 07Buy67.321,486100,0333,235,657Sep 11 10:47 AM
Darling David EEVP, COOSep 06Sale67.4519,2501,298,412103,780Sep 07 09:11 PM
Darling David EEVP, COOSep 05Sale68.4125017,102123,030Sep 07 09:11 PM
Rubio Samuel REVP, CFO & CAOAug 14Sale62.3721,7881,358,918117,677Aug 16 08:56 PM
ROBOTTI ROBERTDirectorAug 10Buy63.0048,2003,036,4463,234,171Aug 11 04:39 PM
12345671020